Nasopharyngeal Carcinoma
📧 Sign up to get email alerts when something new happens for Nasopharyngeal Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-08-19Clinical Trial Update: A Phase III Trial in NPC With Post-radiation Detectable Plasma EBV DNA [Phase 3]
A Phase III trial investigating post-radiation detectable plasma EBV DNA in nasopharyngeal carcinoma has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-08-15Clinical Trial Update: Epstein-Barr Virus Reactivation and the Effect of EGCG on Virus Reactivation in Remission Patients [NA]
A completed clinical trial evaluating whether epigallocatechin gallate (EGCG) influences Epstein-Barr virus reactivation in patients in remi…
-
CLINICAL_TRIALS trial_result · 2025-08-15Clinical Trial Update: Screening Effect of Dual-energy CT Combined With Nasopharyngeal Endoscopy for Screening Nasopharyngeal Carcinoma
A clinical trial update describes screening nasopharyngeal carcinoma using dual-energy CT combined with nasopharyngeal endoscopy; the study …
-
CLINICAL_TRIALS trial_result · 2025-08-14Clinical Trial Update: Tislelizumab Plus GX Versus Tislelizumab Plus GP in the Treatment of R/M NPC [Phase 3]
Phase 3 trial update comparing tislelizumab plus GX versus tislelizumab plus GP in relapsed/refractory nasopharyngeal carcinoma is currently…
-
CLINICAL_TRIALS trial_result · 2025-08-07Clinical Trial Update: Trail Evaluating Carbon Ion Radiotherapy (3 GyE Per Fraction) for Locally Recurrent Nasopharyngeal Carcinoma [Phase 1, Phase 2]
A Phase 1/2 trial evaluating carbon ion radiotherapy (3 GyE per fraction) for locally recurrent nasopharyngeal carcinoma has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-07-18Clinical Trial Update: Ivonescimab Combined With Chemoradiotherapy in High-Risk Locoregionally Advanced Nasopharyngeal Carcinoma [Phase 2]
A Phase 2 clinical trial evaluating Ivonescimab in combination with chemoradiotherapy for high-risk locoregionally advanced nasopharyngeal c…
-
CLINICAL_TRIALS trial_result · 2025-07-17Clinical Trial Update: Nivolumab Combined With Chemoradiotherapy Sparing Concurrent Cisplatin in Nasopharyngeal Carcinoma [Phase 2]
A Phase 2 trial investigated combining nivolumab with chemoradiotherapy while omitting cisplatin in nasopharyngeal carcinoma; the study has …
-
CLINICAL_TRIALS trial_result · 2025-07-16Clinical Trial Update: PD-1 Blockade Combined With De-intensified Chemoradiotherapy Sparing Concurrent Cisplatin in Nasopharyngeal Carcinoma [Phase 3]
Phase 3 clinical trial evaluating PD-1 blockade with de-intensified chemoradiotherapy that spares concurrent cisplatin in Nasopharyngeal Car…
-
CLINICAL_TRIALS trial_result · 2025-07-14Clinical Trial Update: Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099280 in Participants With Advanced Solid Tumors [Phase 1]
This Phase 1 trial reports on the safety, tolerability, pharmacokinetics, and pharmacodynamics of INCB099280 in participants with advanced s…
-
CLINICAL_TRIALS trial_result · 2025-07-08Clinical Trial Update: Neoadjuvant Therapy of GP Chemotherapy Combined With Tislelizumab in Locoregionally Advanced NPC [Phase 2]
Phase 2 neoadjuvant trial evaluating GP chemotherapy plus tislelizumab in locoregionally advanced nasopharyngeal carcinoma. The study status…
-
CLINICAL_TRIALS trial_result · 2025-06-29Clinical Trial Update: Impact of Vitamin D on Therapeutic Respons in NPC Chemoradiated Patients [NA]
A clinical trial is evaluating whether vitamin D supplementation influences therapeutic response in nasopharyngeal carcinoma patients treate…
-
CLINICAL_TRIALS trial_result · 2025-06-26Clinical Trial Update: Avelumab With Valproic Acid in Virus-associated Cancer [Phase 2]
Phase 2 trial evaluating the PD-L1 inhibitor avelumab in combination with valproic acid for virus-associated cancers has completed; the upda…
-
CLINICAL_TRIALS trial_result · 2025-06-10Clinical Trial Update: Effect of Oral Nutritional Supplements on Body Weight Loss of Patients With Nasopharyngeal Carcinoma [NA]
Completed clinical trial evaluating the effect of oral nutritional supplements on body weight loss in nasopharyngeal carcinoma patients.
-
CLINICAL_TRIALS trial_result · 2025-05-16Clinical Trial Update: Efficacy of Ulinastatin for Reducing Radiation-Induced Oral Mucositis in Nasopharyngeal Carcinoma Patients [Phase 3]
A Phase 3 trial evaluated the efficacy of ulinastatin to reduce radiation-induced oral mucositis in patients with nasopharyngeal carcinoma, …
-
CLINICAL_TRIALS trial_result · 2025-04-27Clinical Trial Update: Clincal Study of Reduced Target Radiotherapy in Nasopharyngeal Carcinoma [NA]
An update on a completed clinical trial studying reduced target radiotherapy for nasopharyngeal carcinoma. The study explored whether reduci…
-
CLINICAL_TRIALS trial_result · 2025-04-18Clinical Trial Update: Evaluation of Swallowing Muscles Using Ultrasonography and Shear Wave Elastography in Patients Receiving Radiotherapy for Nasopharyngeal Carcinoma Diagnosis
Clinical trial update on evaluating swallowing muscles using ultrasonography and shear wave elastography in patients receiving radiotherapy …
-
CLINICAL_TRIALS trial_result · 2025-04-02Clinical Trial Update: PD-1 Antibody Sintilimab Combined With Capecitabine as Adjuvant Therapy for High-Risk Nasopharyngeal Carcinoma [Phase 3]
Phase 3 clinical trial evaluating sintilimab plus capecitabine as adjuvant therapy for high-risk nasopharyngeal carcinoma; the trial status …
-
CLINICAL_TRIALS trial_result · 2025-03-20Clinical Trial Update: GP Combined with Toripalimab Versus GP Induction Chemotherapy for Advanced Childhood Nasopharyngeal Carcinoma [Phase 2]
Phase 2 trial comparing GP plus toripalimab versus GP induction chemotherapy in children with advanced nasopharyngeal carcinoma; study statu…
-
CLINICAL_TRIALS trial_result · 2025-03-07Clinical Trial Update: A Study of Penpulimab Combination Therapy in Patients With Advanced Nasopharyngeal Carcinoma [Phase 2]
Phase 2 study evaluating penpulimab in combination therapy for advanced nasopharyngeal carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2025-03-05Clinical Trial Update: Concurrent Chemoradiotherapy With Nimotuzumab for High Risk Nasopharyngeal Carcinoma [Phase 2]
Phase 2 clinical trial update evaluating nimotuzumab in combination with concurrent chemoradiotherapy for high-risk nasopharyngeal carcinoma…
-
CLINICAL_TRIALS trial_result · 2025-02-27Clinical Trial Update: A Study of Anti-PD-1 AK105 in Patients With Metastatic Nasopharyngeal Carcinoma [Phase 2]
A Phase 2 trial evaluating AK105, an anti-PD-1 therapy, in metastatic nasopharyngeal carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2025-02-24Clinical Trial Update: Nanatinostat Plus Valganciclovir in Advanced EBV+ Solid Tumors and in Combination With Pembrolizumab in EBV+ RM-NPC [Phase 1]
Phase 1 clinical trial evaluating Nanatinostat with valganciclovir (and in combination with pembrolizumab) for EBV-positive solid tumors, in…
-
CLINICAL_TRIALS trial_result · 2025-02-24Clinical Trial Update: Most Closely Matched 3rd Party Rapidly Generated LMP, BARF1 And EBNA1 Specific CTL, EBV-Positive Lymphoma (MABEL) [Phase 1]
Phase 1 trial evaluating LMP-, BARF1-, and EBNA1-specific cytotoxic T cells for EBV-positive lymphomas; Hodgkin and Non-Hodgkin lymphoma inc…
-
CLINICAL_TRIALS trial_result · 2025-01-28Clinical Trial Update: PD-1 Antibody Combined With Chemoradiotherapy in Recurrent Nasopharyngeal Carcinoma Patients [Phase 3]
Phase 3 clinical trial evaluating a PD-1 antibody with chemoradiotherapy for recurrent nasopharyngeal carcinoma. The study is currently recr…
-
CLINICAL_TRIALS trial_result · 2025-01-28Clinical Trial Update: Programmed Death-1 (PD-1) Antibody Combined With Chemoradiotherapy in High-risk Recurrent Nasopharyngeal Carcinoma [Phase 2]
Phase 2 trial assessing a PD-1 antibody in combination with chemoradiotherapy for high-risk recurrent nasopharyngeal carcinoma; the trial is…